Fabry disease in donor kidneys with 3- and 12-year follow-up after transplantation
Enzyme replacement therapy (ERT) has been introduced for Fabry disease and has been reported to clear some renal cell types of accumulated glycolipids and to reduce the accumulation in other cell types. We describe two patients without Fabry disease who were transplanted with kidney allografts from a male donor with Fabry disease. Biopsies were taken at transplantation and after 3 years in the first case and after 12 years in the second case. Even though these Fabry kidney allografts for many years had been exposed to normal levels of circulating α-galactosidase A (α-gal-A), the amount of accumulated lysosomal deposits in the podocytes remained unchanged. Additionally, small deposits were also found in tubular cells and glomerular endothelial cells as long as 12 years after transplantation.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2010 |
|---|---|
| Erschienen: |
2010 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:3 |
|---|---|
| Enthalten in: |
NDT plus - 3(2010), 3 vom: 26. Juni, Seite 303-305 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Aasebø, Willy [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Enzyme replacement therapy |
|---|
| Anmerkungen: |
Date Revised 30.09.2020 published: Print-Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1093/ndtplus/sfq036 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM273345354 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM273345354 | ||
| 003 | DE-627 | ||
| 005 | 20231225001019.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2010 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/ndtplus/sfq036 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0911.xml |
| 035 | |a (DE-627)NLM273345354 | ||
| 035 | |a (NLM)28657066 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Aasebø, Willy |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Fabry disease in donor kidneys with 3- and 12-year follow-up after transplantation |
| 264 | 1 | |c 2010 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 30.09.2020 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Enzyme replacement therapy (ERT) has been introduced for Fabry disease and has been reported to clear some renal cell types of accumulated glycolipids and to reduce the accumulation in other cell types. We describe two patients without Fabry disease who were transplanted with kidney allografts from a male donor with Fabry disease. Biopsies were taken at transplantation and after 3 years in the first case and after 12 years in the second case. Even though these Fabry kidney allografts for many years had been exposed to normal levels of circulating α-galactosidase A (α-gal-A), the amount of accumulated lysosomal deposits in the podocytes remained unchanged. Additionally, small deposits were also found in tubular cells and glomerular endothelial cells as long as 12 years after transplantation | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Fabry disease | |
| 650 | 4 | |a enzyme replacement therapy | |
| 650 | 4 | |a histological changes | |
| 650 | 4 | |a kidney | |
| 650 | 4 | |a transplantation | |
| 700 | 1 | |a Strøm, Erik H |e verfasserin |4 aut | |
| 700 | 1 | |a Hovig, Torstein |e verfasserin |4 aut | |
| 700 | 1 | |a Undset, Liv H |e verfasserin |4 aut | |
| 700 | 1 | |a Heiberg, Arvid |e verfasserin |4 aut | |
| 700 | 1 | |a Jenssen, Trond |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t NDT plus |d 2008 |g 3(2010), 3 vom: 26. Juni, Seite 303-305 |w (DE-627)NLM182458822 |x 1753-0784 |7 nnns |
| 773 | 1 | 8 | |g volume:3 |g year:2010 |g number:3 |g day:26 |g month:06 |g pages:303-305 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/ndtplus/sfq036 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 3 |j 2010 |e 3 |b 26 |c 06 |h 303-305 | ||